Madam Speaker, I enjoyed my colleague's speech.
I would like to clarify something that is of particular interest to me. In our national capital, Quebec City, there is a pharmaceutical laboratory called Medicago. We met with the people in charge last spring. They are absolutely fantastic people. They were very worried because the federal funding they were supposed to get was not coming. The feds were funding other pharmaceutical enterprises around the world, but not Medicago.
If the government had been quicker to invest in Medicago, all Canadians would probably be getting a Quebec-made vaccine.
I would like my colleague to comment on how long it took the government to support Medicago.